This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krupenko, S. A. Articles by Oleinik, N. V. Search for Related Content PubMed PubMed Citation Articles by Krupenko, S. A. Articles by Oleinik, N. V.

10-Formyltetrahydrofolate Dehydrogenase, One of the Major Folate Enzymes, Is Down-Regulated in Tumor Tissues and Possesses Suppressor Effects on Cancer Cells¹

Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425

Our studies showed that an abundant folate enzyme, 10-formyltetrahydrofolatedehydrogenase (FDH), is strongly down-regulated in several types of cancer on both the mRNA and the protein level. Transient expression of FDH in several human prostate cancer cell lines, a hepatocarcinoma cell line, HepG2, and a lung cancer cell line, A549, suppressed proliferation and resulted in cytotoxicity. In contrast, overexpression of a catalytically inactive FDH mutant did not inhibit proliferation, which suggests that the suppressor effect of FDH is a result of its enzymatic function. Because the FDH substrate, 10-formyltetrahydrofolate, is required for de novo purine biosynthesis, we hypothesized that the inhibitory effects of FDH occur through the depletion of intracellular 10-formyltetrahydrofolate followed by the loss of de novo purine biosynthesis. The ultimate impact is diminished DNA/RNA biosynthesis. Indeed, supplementation of FDH-overexpressing cells with 5-formyltetrahydrofolate or hypoxanthine reversed the FDH growth-inhibitory effects. Hence, down-regulation of FDH in tumors is proposed to be one of the cellular mechanisms that enhance proliferation.

This article has been cited by other articles:

				J. D. Cahoy, B. Emery, A. Kaushal, L. C. Foo, J. L. Zamanian, K. S. Christopherson, Y. Xing, J. L. Lubischer, P. A. Krieg, S. A. Krupenko, et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function J. Neurosci., January 2, 2008; 28(1): 264 - 278. [Abstract] [Full Text] [PDF]

				H. Donato, N. I. Krupenko, Y. Tsybovsky, and S. A. Krupenko 10-Formyltetrahydrofolate Dehydrogenase Requires a 4'-Phosphopantetheine Prosthetic Group for Catalysis J. Biol. Chem., November 23, 2007; 282(47): 34159 - 34166. [Abstract] [Full Text] [PDF]

				M. C. Anguera, M. S. Field, C. Perry, H. Ghandour, E.-P. Chiang, J. Selhub, B. Shane, and P. J. Stover Regulation of Folate-mediated One-carbon Metabolism by 10-Formyltetrahydrofolate Dehydrogenase J. Biol. Chem., July 7, 2006; 281(27): 18335 - 18342. [Abstract] [Full Text] [PDF]

				S. N. Reuland, A. P. Vlasov, and S. A. Krupenko Modular organization of FDH: Exploring the basis of hydrolase catalysis Protein Sci., May 1, 2006; 15(5): 1076 - 1084. [Abstract] [Full Text] [PDF]

				L. E. Epperson, T. A. Dahl, and S. L. Martin Quantitative Analysis of Liver Protein Expression During Hibernation in the Golden-mantled Ground Squirrel Mol. Cell. Proteomics, September 1, 2004; 3(9): 920 - 933. [Abstract] [Full Text] [PDF]

				A. A. Chumanevich, S. A. Krupenko, and C. Davies The Crystal Structure of the Hydrolase Domain of 10-Formyltetrahydrofolate Dehydrogenase: MECHANISM OF HYDROLYSIS AND ITS INTERPLAY WITH THE DEHYDROGENASE DOMAIN J. Biol. Chem., April 2, 2004; 279(14): 14355 - 14364. [Abstract] [Full Text] [PDF]